Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by mercedesmanon Nov 25, 2020 12:31pm
762 Views
Post# 31970366

It sure seems like ....

It sure seems like .......word is starting to leak out about this hidden gem...and all the exciting diagnostic opportunites that they are on the cusp of commercializing.

...and or it could be the excitement and anticipation of three impending FDA rulings (two of which are directly Covid related and timely) is starting to take hold with some new investors.  Perhaps some neighbours to the south are waking up to the opportunity ?!

Necessity is the mother of invention, and the ICU crisis is peaking there (with at least another 2 -3 terrible months ahead despite vaccines being on the way)  More than 2000 people dying every day (in the US)  tends to get people's attention. Covid is a crisis that requires greater testing, triaging, vaccination, more treatments and antibody testing. What SQI brings to the table should no longer be kept under wraps - if indeed it works as advertized.


Once the daily volume starts to approach 1/2 million shares (a mere $ 125k CAD) then it will become increasingly difficult for the handlers to keep this pony corralled any longer in the # .25 to .28 pens.

JMHO

MM
<< Previous
Bullboard Posts
Next >>